Im I. Na

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Comparative Analysis of Primary and Second Primary Multiple Myeloma: A Propensity Score-Matched Study.

Comparative Analysis of Primary and Second Primary Multiple Myeloma: A Propensity Score-Matched Study.

Journal: Clinical Medicine Insights. Oncology

Published: April 30, 2025

Therapy-related myeloid neoplasms in Korean patients with ovarian or primary peritoneal cancer treated with poly(ADP-ribose) polymerase inhibitors.

Therapy-related myeloid neoplasms in Korean patients with ovarian or primary peritoneal cancer treated with poly(ADP-ribose) polymerase inhibitors.

Journal: Translational cancer research

Published: July 03, 2024

Secondary hematological malignancies in patients with sarcoma: A single‑center retrospective study.

Secondary hematological malignancies in patients with sarcoma: A single‑center retrospective study.

Journal: Oncology letters

Published: November 10, 2023

A Phase II Study of 131I-rituximab for Patients With Relapsed or Refractory Marginal Zone Lymphoma.

A Phase II Study of 131I-rituximab for Patients With Relapsed or Refractory Marginal Zone Lymphoma.

Journal: Clinical Medicine Insights. Oncology

Published: August 30, 2023

Radioimmunotherapy with 131 I-rituximab for patients with relapsed or refractory follicular or mantle cell lymphoma.

Radioimmunotherapy with 131 I-rituximab for patients with relapsed or refractory follicular or mantle cell lymphoma.

Journal: Asia-Pacific journal of clinical oncology

Published: November 02, 2022

Association of EGFR mutations in second primary lung cancer and HER2 expression in breast cancer survivors.

Association of EGFR mutations in second primary lung cancer and HER2 expression in breast cancer survivors.

Journal: Translational cancer research

Published: July 09, 2021

Factors that Predict Clinical Benefit of EGFR TKI Therapy in Patients with EGFR Wild-Type Lung Adenocarcinoma.

Factors that Predict Clinical Benefit of EGFR TKI Therapy in Patients with EGFR Wild-Type Lung Adenocarcinoma.

Journal: Tuberculosis and respiratory diseases

Published: January 09, 2018

Identification of atopic dermatitis phenotypes with good responses to probiotics (Lactobacillus plantarum CJLP133) in children.

Identification of atopic dermatitis phenotypes with good responses to probiotics (Lactobacillus plantarum CJLP133) in children.

Journal: Beneficial microbes

Published: October 17, 2017

Sex-specific incidence of EGFR mutation and its association with age and obesity in lung adenocarcinomas: a retrospective analysis.

Sex-specific incidence of EGFR mutation and its association with age and obesity in lung adenocarcinomas: a retrospective analysis.

Journal: Journal of cancer research and clinical oncology

Published: January 07, 2017

CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy.

CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy.

Journal: Cancer research and treatment

Published: July 22, 2016

Epidermal growth factor receptor mutations and brain metastasis in patients with nonadenocarcinoma of the lung.

Epidermal growth factor receptor mutations and brain metastasis in patients with nonadenocarcinoma of the lung.

Journal: Journal of cancer research and therapeutics

Published: April 14, 2016

Visceral adipose tissue is prognostic for survival of diffuse large B cell lymphoma treated with frontline R-CHOP.

Visceral adipose tissue is prognostic for survival of diffuse large B cell lymphoma treated with frontline R-CHOP.

Journal: Annals of hematology

Published: October 19, 2015

Showing 1-12 of 22

Last Updated: 09/26/2026